Status:
COMPLETED
Letrozole Step up Protocol for Ovulation Induction in Infertile Women With Polycystic Ovary Syndrome
Lead Sponsor:
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Conditions:
Polycystic Ovarian Syndrome (PCOS)
Infertility
Eligibility:
FEMALE
18-35 years
Phase:
PHASE3
Brief Summary
The goal of this clinical trial is to learn if drug letrozole in step up dose works better to treat anovulation in infertile women with polycystic ovary syndrome. It will also learn about the safety o...
Detailed Description
Background: Polycystic ovary syndrome (PCOS) is the largest single cause of anovulatory infertility. Letrozole, an aromatase inhibitor, has been regarded as the first-line drug for ovulation induction...
Eligibility Criteria
Inclusion
- PCOS women with subfertility
- Selected for ovulation induction
Exclusion
- Body mass index (BMI) ˂18 and ≥30 kg/m2,
- Women with other infertility factors (endometriosis, suspected tubal factor, and uterine causes of infertility)
- Male factor infertility
Key Trial Info
Start Date :
January 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT07143682
Start Date
January 8 2023
End Date
June 30 2024
Last Update
December 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bangabandhu Sheikh Mujib Medical University
Dhaka, Bangladesh, 1200